Celeste Fralick - Sep 30, 2024 Form 4 Insider Report for Aspira Women's Health Inc. (AWH)

Role
Director
Signature
/s/ Celeste Fralick
Stock symbol
AWH
Transactions as of
Sep 30, 2024
Transactions value $
$0
Form type
4
Date filed
10/2/2024, 05:19 PM
Previous filing
Aug 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AWH Common Stock Options Exercise $0 +5K +12.3% $0.00 45.7K Sep 30, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AWH Restricted Stock Units Options Exercise $0 -5K -25% $0.00 15K Sep 30, 2024 Common Stock 5K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
F2 Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
F3 On August 22, 2024, the reporting person was granted 20,000 RSUs, 5,000 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.